Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel | Zendy

Shokoufeh Hajsadeghi | Zendy; Mandana Chitsazan | Zendy; Mitra Chitsazan | Zendy; Negar Salehi | Zendy; Ahmad Amin | Zendy; Arash Amin Bidokhti | Zendy; Nima Babaali | Zendy; Armin Bordbar | Zendy; Maral Hejrati | Zendy; Samar Moghadami | Zendy

Open Access

Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel

Author(s) -

Shokoufeh Hajsadeghi,

Mandana Chitsazan,

Mitra Chitsazan,

Negar Salehi,

Ahmad Amin,

Arash Amin Bidokhti,

Nima Babaali,

Armin Bordbar,

Maral Hejrati,

Samar Moghadami

Publication year - 2016

Publication title -

clinical medicine insights cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 21

ISSN - 1179-5468

DOI - 10.4137/cmc.s32804

Subject(s) - clopidogrel , prasugrel , medicine , interquartile range , percutaneous coronary intervention , conventional pci , loading dose , c reactive protein , maintenance dose , cardiology , gastroenterology , myocardial infarction , inflammation

A growing body of clinical and laboratory evidence indicates that inflammation plays a crucial role in atherosclerosis. In the present study, we compared the effects of clopidogrel and prasugrel on high-sensitivity C-reactive protein (hs-CRP) in patients undergoing percutaneous coronary intervention (PCI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research